The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lipid metabolic gene expression and association with decreased overall survival and immunogenicity in KRAS-STK11 NSCLC.
 
Joshua Pothen
No Relationships to Disclose
 
Jen Godden
Employment - Tempus AI, Inc.
Travel, Accommodations, Expenses - Tempus
 
Denise Shieh
Stock and Other Ownership Interests - Tempus AI
 
Stamatina Fragkogianni
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Jacob Mercer
Employment - Helsinn Therapeutics; QED Therapeutics; Tempus AI
Stock and Other Ownership Interests - Bridgebio
Travel, Accommodations, Expenses - Helsinn Therapeutics; Tempus AI
 
Melissa Stoppler
Employment - Gilead Sciences (I); Roche/Genentech (I); TEMPUS AI, INC
Stock and Other Ownership Interests - Gilead Sciences (I); Roche/Genentech (I); TEMPUS AI, Inc
 
Daniel Principe
No Relationships to Disclose
 
Ryan Nguyen
Consulting or Advisory Role - Merck; Novartis; Regeneron
Speakers' Bureau - Merck
Research Funding - Exelixis
Travel, Accommodations, Expenses - Merck
 
Kamya Sankar
Research Funding - Black Diamond Therapeutics (Inst); Genentech/Roche (Inst); Harpoon therapeutics (Inst); Lilly (Inst); Merck (Inst)
 
Koosha Paydary
No Relationships to Disclose
 
Mary Fidler
Honoraria - Daiichi Sankyo/Astra Zeneca; EMD Serono
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Merus; Novocure; Oncohost; Proventus Group; Tempus
Speakers' Bureau - EMD Serono
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genentech (Inst); Gilead Sciences (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono
 
Frank Weinberg
Honoraria - IDEOlogy Health
Consulting or Advisory Role - Boehringer Ingelheim; Jazz Pharmaceuticals; Regeneron; Tempus; Tempus
Speakers' Bureau - Amgen; AstraZeneca; G1 Therapeutics; Jazz Pharmaceuticals; Regeneron; Tempus